News
HKBU partners with CR Jiangzhong and China Resources Research Institute of Science & Technology for post COVID-19 syndrome study
2 May, 2023
HKBU is committed to drug discovery to enhance human lives. We signed a research agreement with CR Jiangzhong and China Resources Research Institute of Science & Technology on 2 May 2023, which is a follow-up to the Memorandum of Understanding between the University and China Resources signed on 7 December, 2022. The agreement focuses on the study of shenlingcao (參靈草) for treating post-Covid-19 fatigue.
The research agreement sets out the project direction, mechanism, and implementation details. The signing parties include HKBU Associate Vice-President (Chinese Medicine Development) Prof. Bian Zhaoxiang, CR JiangZhong General Manager Mr Liu Weiquan, and China Resources Enterprise Vice President Mr Zhizhe. The ceremony was witnessed by HKBU Interim Chief Innovation Officer Prof. Terence Lau and China Resources Deputy General Manager Mr Han Yuewei.
Prof. Terence Lau said HKBU’s Chinese medicine arm has developed rapidly in recent years. The research team is keen to promote collaboration between Chinese and Western medicine, as well as driving Chinese medicine standardisation and internationalisation projects, to bring high quality basic research, clinical study and new drug development. Mr Han Yuewei hoped that the collaboration with HKBU can enhance the public understanding towards the efficacy and use of new Chinese medicine, and gain international recognition for Chinese medicine through clinical study.
During the occasion, Prof. Bian Zhaoxiang shared the latest developments in HKBU's Chinese Medicine and introduced the shenlingcao research’s background, framework, standard and timeline, while China Resources - Technology and Innovation Department Deputy General Manager Mr Chen Lei shared the company's advancements in technology and innovation. After the signing ceremony, Prof. Bian brought the group to visit the Dr & Mrs Hung Hin Shiu Museum of Chinese Medicine at HKBU.
HKBU is excited about the potential benefits of this research collaboration for society as it addresses a pressing need in the fight against this pandemic. By working with our partners, we hope to make a significant impact on the health and well-being of those affected by COVID-19.